ArticleACS omega2026
Suspect Screening for PFAS in Groundwater with an Accessible LC-MS Workflow.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Groundwater in North America is contaminated with per- and polyfluoroalkyl substances (PFAS) at more than 9500 locations. A major source of this contamination is aqueous film-forming foam (AFFF), widely used for fire suppression at military facilities and airfields. Many of the thousands of PFAS remain poorly characterized and are not amenable to targeted quantitative analytical methods, which allow them to remain undetected. Suspect screening, an analytical strategy that searches for potential or likely compounds from a predefined list without requiring analytical reference standards, combined with liquid chromatography-high resolution tandem mass spectrometry (LC-HRMS/MS), has emerged as an alternative or complementary approach to classical targeted analysis. Herein, an accessible suspect screening workflow was developed using data-dependent acquisitions and the NIST suspect list of 4712 PFAS, processed with TraceFinder software, followed by FreeStyle MS
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.